This review discusses pharmacology, dosage, adverse events and key trials. It also provides commentary and recommendations from Associate Andrew Östör, a Consultant Rheumatologist at Cabrini Medical Centre and Researcher at Emeritus Research, Melbourne, Australia.
Please login below to download this issue (PDF)